Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV000516381 | SCV000614145 | likely pathogenic | not provided | 2017-05-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002512824 | SCV003439235 | pathogenic | Myofibrillar myopathy 3 | 2024-10-30 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with phenylalanine, which is neutral and non-polar, at codon 39 of the MYOT protein (p.Ser39Phe). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with MYOT-related conditions (PMID: 16380616, 22106715). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 5839). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. For these reasons, this variant has been classified as Pathogenic. |
Revvity Omics, |
RCV002512824 | SCV004238301 | likely pathogenic | Myofibrillar myopathy 3 | 2023-08-14 | criteria provided, single submitter | clinical testing | |
OMIM | RCV002512824 | SCV000026378 | pathogenic | Myofibrillar myopathy 3 | 2005-12-27 | no assertion criteria provided | literature only |